Mesa Laboratories Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	28.98	27.32	28.21	32.91	49.35	263.87
Short-Term Investments	1.5	1.75	1.9	-	-	-
Cash & Short-Term Investments	30.47	29.07	30.11	32.91	49.35	263.87
Cash Growth	-5.65%	-3.45%	-8.50%	-33.31%	-81.30%	224.24%
Receivables	40.23	41.97	39.06	42.55	41.22	23.79
Inventory	26.56	25.37	32.68	34.64	24.61	11.18
Prepaid Expenses	3.57	2.36	2.93	8.87	9.14	4.92
Other Current Assets	4.8	3.91	4.58	-	-	-
Total Current Assets	105.63	102.69	109.35	118.98	124.32	303.75
Property, Plant & Equipment	31.6	48.72	41.44	36.84	38.82	23.8
Goodwill	189.3	181.76	180.1	286.44	291.17	160.84
Other Intangible Assets	89.65	96.88	113.75	216.82	250.12	111.74
Long-Term Deferred Tax Assets	1.47	1.37	1.29	1.08	1.32	0.62
Other Long-Term Assets	17.2	1.94	0.87	1.68	1.63	0.73
Total Assets	434.85	433.35	446.8	661.83	707.37	601.48
Accounts Payable	5.25	5.75	6.04	6.13	7.9	4.47
Accrued Expenses	23.47	27.46	18.19	17.67	21.88	16.15
Current Portion of Long-Term Debt	5.16	101.05	-	-	-	-
Current Portion of Leases	3.89	3.52	2.99	2.87	2.77	1.02
Current Income Taxes Payable	2.07	2.16	1.62	0.99	0.93	1.65
Current Unearned Revenue	14.56	14.71	15.48	15.69	13.83	8.78
Other Current Liabilities	-	9.32	-	-	0.75	0.51
Total Current Liabilities	54.4	163.96	44.31	43.36	48.06	32.58
Long-Term Debt	160.97	76.9	221.7	183.27	218.37	145.68
Long-Term Leases	-	12.38	6.61	5.75	7.44	0.68
Long-Term Unearned Revenue	0.01	0.09	0.21	0.4	-	-
Long-Term Deferred Tax Liabilities	21.83	20.18	19.78	34.03	39.22	16.28
Other Long-Term Liabilities	10.95	-	8.79	1.54	0.49	0.04
Total Liabilities	248.16	273.52	301.4	268.35	313.57	195.25
Common Stock	368.56	358.54	343.64	332.08	313.46	317.65
Retained Earnings	-180.73	-188.94	-183.49	74.2	76.68	72.46
Comprehensive Income & Other	-1.14	-9.78	-14.76	-12.8	3.67	16.12
Shareholders' Equity	186.69	159.83	145.39	393.48	393.8	406.23
Total Liabilities & Equity	434.85	433.35	446.8	661.83	707.37	601.48
Total Debt	170.02	193.85	231.3	191.89	228.57	147.38
Net Cash (Debt)	-139.55	-164.78	-201.19	-158.98	-179.22	116.49
Net Cash Per Share	-25.42	-30.40	-37.35	-29.66	-33.59	22.73
Filing Date Shares Outstanding	5.52	5.46	5.41	5.37	5.27	5.14
Total Common Shares Outstanding	5.52	5.46	5.39	5.37	5.27	5.14
Working Capital	51.24	-61.28	65.04	75.62	76.26	271.17
Book Value Per Share	33.79	29.30	26.95	73.28	74.79	79.02
Tangible Book Value	-92.26	-118.81	-148.46	-109.78	-147.48	133.65
Tangible Book Value Per Share	-16.70	-21.78	-27.52	-20.45	-28.01	26.00
Land	-	0.89	0.89	0.89	0.89	0.89
Buildings	-	23.28	23.48	22.01	21.54	18.86
Machinery	-	25.79	23.15	18.89	21.86	16.51
Construction In Progress	-	1.61	1.38	1.74	0.49	0.99
Order Backlog	-	43.2	25.5	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.